Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO16493 | Nasutitermes ephratae | Species | Termitoidae | Eukaryota | UNPD* | |||
NPO13642 | Pastinaca sativa | Species | Apiaceae | Eukaryota | UNPD* | |||
NPO17024 | Vitis vinifera | Species | Vitaceae | Eukaryota | UNPD* | |||
NPO26327 | Chaenomeles sinensis | Species | Rosaceae | Eukaryota | UNPD* | |||
NPO16369 | Lepisorus ussuriensis | Species | Polypodiaceae | Eukaryota | UNPD* | |||
NPO14395 | Lysimachia mauritiana | Species | Primulaceae | Eukaryota | UNPD* | |||
NPO17472 | Drechslera avenae | Species | Pleosporaceae | Eukaryota | UNPD* | |||
NPO15803 | Artemisia assoana | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO2507 | Rumex maritimus | Species | Polygonaceae | Eukaryota | UNPD* | |||
NPO17400 | Peltostigma guatemalense | Species | Rutaceae | Eukaryota | UNPD* | |||
NPO17633 | Viguiera incana | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO7562 | Premna odorata | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO17169 | Adiantum lunulatum | Species | Pteridaceae | Eukaryota | UNPD* | |||
NPO18022 | Naucleopsis ternstroemiiflora | Species | Moraceae | Eukaryota | UNPD* | |||
NPO4181 | Pseudoalteromonas luteoviolacea | Species | Pseudoalteromonadaceae | Bacteria | UNPD* | |||
NPO1087 | Pterocarpus santalinus | Species | Fabaceae | Eukaryota | TCM_Taiwan* | |||
NPO9516 | Gnetum latifolium | Species | Gnetaceae | Eukaryota | UNPD* | |||
NPO13167 | Scutellaria amoena | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO12714 | Dracaena cochinchinensis | Species | Asparagaceae | Eukaryota | TCM_Taiwan* | |||
NPO13847 | Streptomyces avermitilis | Species | Streptomycetaceae | Bacteria | UNPD* | |||
NPO6160 | Vaccinium oxycoccos | Species | Ericaceae | Eukaryota | UNPD* | |||
NPO17024 | Vitis vinifera | Species | Vitaceae | Eukaryota | fruit |
PMID[11312782] |
||
NPO17094 | Sinularia depressa | Species | Alcyoniidae | Eukaryota | UNPD* | |||
NPO947 | Rauvolfia vomitoria | Species | Apocynaceae | Eukaryota | UNPD* | |||
NPO17024 | Vitis vinifera | Species | Vitaceae | Eukaryota | Leaves |
PMID[11312782] |
||
NPO13407 | Goniothalamus malayanus | Species | Annonaceae | Eukaryota | UNPD* | |||
NPO18129 | Notopterygii rhizoma et radix | NA | NA | NA | TCMSP* | |||
NPO20312 | Pterocarpus marsupium | Species | Fabaceae | Eukaryota | heartwood | DOI[10.1021/np50031a029] | ||
NPO14859 | Bishovia boliviensis | NA | NA | NA | UNPD* | |||
NPO495 | Daemonorops draco | Species | Arecaceae | Eukaryota | TM-MC* | |||
NPO30125 | Notopterygium forbesii | NA | NA | NA | TCM_Taiwan* | |||
NPO17942 | Wikstroemia retusa | Species | Thymelaeaceae | Eukaryota | UNPD* | |||
NPO29417 | Fallopia multiflora | Species | Polygonaceae | Eukaryota | TM-MC* | |||
NPO30784 | Vaccinium | Genus | Ericaceae | Eukaryota | fruit |
PMID[15264904] |
||
NPO17544 | Acacia adunca | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO15659 | Zanthoxylum tetraspermum | Species | Rutaceae | Eukaryota | UNPD* | |||
NPO15552 | Anacystis montana | NA | NA | NA | UNPD* | |||
NPO8506 | Cotyledon secunda | Species | Crassulaceae | Eukaryota | UNPD* | |||
NPO15063 | Leathesia nana | Species | Chordariaceae | Eukaryota | UNPD* | |||
NPO20812 | Soymida febrifuga | Species | Meliaceae | Eukaryota | Myanmar |
PMID[19689125] |
||
NPO17865 | Amathia pinnata | Species | Vesiculariidae | Eukaryota | UNPD* | |||
NPO21724 | Sabina sargentii | NA | NA | NA | UNPD* | |||
NPO16857 | Hypericum laricifolium | Species | Hypericaceae | Eukaryota | UNPD* | |||
NPO6881 | Caragana aurantiaca | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO16089 | Dumortiera hirsuta | Species | Dumortieraceae | Eukaryota | UNPD* | |||
NPO17242 | Laurencia spectabilis | Species | Rhodomelaceae | Eukaryota | UNPD* | |||
NPO11917 | Asterospicularia laurae | Species | Xeniidae | Eukaryota | UNPD* | |||
NPO17702 | Astragalus sempervirens | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO16731 | Phoebe pittieri | Species | Lauraceae | Eukaryota | UNPD* | |||
NPO10989 | Annona cornifolia | Species | Annonaceae | Eukaryota | UNPD* | |||
NPO4325 | Blastochloris viridis | Species | Hyphomicrobiaceae | Bacteria | UNPD* | |||
NPO15467 | Hedysarum connatum | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO12703 | Eucalyptus melliodora | Species | Myrtaceae | Eukaryota | UNPD* | |||
NPO3964 | Calostephane divaricata | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO16611 | Alstonia spathulata | Species | Apocynaceae | Eukaryota | UNPD* | |||
NPO14685 | Swertia franchetiana | Species | Gentianaceae | Eukaryota | UNPD* | |||
NPO17786 | Marrubium anisodon | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO11641 | Solanum laxum | Species | Solanaceae | Eukaryota | UNPD* | |||
NPO15227 | Helipterum roseum | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO10417 | Ipomoea digitata | Species | Convolvulaceae | Eukaryota | UNPD* | |||
NPO11538 | Salvia syriaca | Species | Lamiaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 35000 | nM | 12877593 |
NPT116 | Cell Line | HL-60 | Homo sapiens | AC50 | = | 70000 | nM | 12877593 |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 4.87 | ug/ml | 12036362 |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | GI50 | = | 6.5 | ug/ml | 12036362 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 2.3 | ug/ml | 12036362 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 4.3 | ug/ml | 12036362 |
NPT2 | Others | Unspecified | GI50 | = | 2.7 | ug/ml | 12036362 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | = | 3.4 | ug/ml | 12036362 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 2.7 | ug/ml | 12036362 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 10000 | nM | 16250636 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 35000 | nM | 16686543 |
NPT116 | Cell Line | HL-60 | Homo sapiens | AC50 | = | 75000 | nM | 16686543 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 42000 | nM | 16686543 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | AC50 | = | 85000 | nM | 16686543 |
NPT3960 | Individual Protein | Bcr/Abl fusion protein | Homo sapiens | IC50 | = | 10000 | nM | 16686543 |
NPT3960 | Individual Protein | Bcr/Abl fusion protein | Homo sapiens | AC50 | = | 45000 | nM | 16686543 |
NPT2 | Others | Unspecified | Inhibition | = | 35 | % | 18042380 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 20 | % | 9214733 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 65 | % | 9214733 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 11 | % | 9214733 |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 700 | nM | 18487053 |
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 820 | nM | 18487053 |
NPT2 | Others | Unspecified | IC50 | = | 19500 | nM | 18487053 | |
NPT453 | Cell Line | HT-1080 | Homo sapiens | IC50 | = | 93400 | nM | 19689125 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 71700 | nM | 19689125 |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 9430 | nM | 19689125 |
NPT2 | Others | Unspecified | IC50 | = | 2960 | nM | 19689125 | |
NPT2 | Others | Unspecified | IC50 | = | 15900 | nM | 19689125 | |
NPT2 | Others | Unspecified | Inhibition | = | 35 | % | 20452207 | |
NPT441 | Individual Protein | Cytochrome P450 19A1 | Homo sapiens | Inhibition | = | 23.52 | % | 20558073 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 23800 | nM | 20627379 |
NPT492 | Cell Line | Caco-2 | Homo sapiens | IC50 | = | 14460 | nM | 20627379 |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 2930.9 | nM | PubChem BioAssay data set |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 3162.3 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 3981.1 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 14581 | nM | PubChem BioAssay data set | |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 56234.1 | nM | PubChem BioAssay data set |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 8912.5 | nM | PubChem BioAssay data set |
NPT60 | Individual Protein | Lysosomal alpha-glucosidase | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT2629 | Individual Protein | FAD-linked sulfhydryl oxidase ALR | Homo sapiens | AC50 | = | 778 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 12589.3 | nM | PubChem BioAssay data set | ||
NPT886 | Cell Line | NIH3T3 | Mus musculus | IC50 | = | 12200 | nM | 21803587 |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 13459.1 | nM | PubChem BioAssay data set | |
NPT886 | Cell Line | NIH3T3 | Mus musculus | IC50 | = | 12190 | nM | 22749392 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 14110 | nM | 22749392 |
NPT2 | Others | Unspecified | IC50 | = | 14050 | nM | 22749392 | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | IC50 | = | 16450 | nM | 22749392 |
NPT179 | Cell Line | A2780 | Homo sapiens | IC50 | = | 15560 | nM | 22749392 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 15860 | nM | 22749392 |
NPT2 | Others | Unspecified | IC50 | = | 17330 | nM | 22749392 | |
NPT2 | Others | Unspecified | IC50 | = | 15180 | nM | 22749392 | |
NPT2 | Others | Unspecified | IC50 | = | 17390 | nM | 22749392 | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 115.8 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 5011.9 | nM | PubChem BioAssay data set | |
NPT157 | Individual Protein | Breast cancer type 1 susceptibility protein | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT953 | Organism | Diplodia seriata | Diplodia seriata | GI | = | 24 | % | 23145924 |
NPT952 | Organism | Lasiodiplodia theobromae | Lasiodiplodia theobromae | GI | = | 24 | % | 23145924 |
NPT1318 | Organism | Diplodia mutila | Diplodia mutila | GI | = | 24 | % | 23145924 |
NPT1319 | Organism | Neofusicoccum luteum | Neofusicoccum luteum | GI | = | 14 | % | 23145924 |
NPT1320 | Organism | Neofusicoccum parvum | Neofusicoccum parvum | GI | = | 14 | % | 23145924 |
NPT950 | Organism | Botryosphaeria dothidea | Botryosphaeria dothidea | GI | = | 14 | % | 23145924 |
NPT1638 | Organism | Eutypa lata | Eutypa lata | IC50 | = | 251000 | nM | 23145924 |
NPT1320 | Organism | Neofusicoccum parvum | Neofusicoccum parvum | IC50 | = | 250000 | nM | 23145924 |
NPT953 | Organism | Diplodia seriata | Diplodia seriata | IC50 | = | 163000 | nM | 23145924 |
NPT2 | Others | Unspecified | EC50 | = | 1220 | nM | 10.1007/s00044-009-9236-2 | |
NPT587 | Tissue | Liver microsome | Rattus norvegicus | EC50 | = | 355000 | nM | 10.1007/s00044-009-9236-2 |
NPT2 | Others | Unspecified | Potency | 18356.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 25929 | nM | PubChem BioAssay data set | ||
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT366 | Individual Protein | Quinone reductase 2 | Homo sapiens | IC50 | = | 5100 | nM | 23953689 |
NPT2 | Others | Unspecified | Activity | = | 212.4 | % | 24462176 | |
NPT2656 | Individual Protein | Ras-related C3 botulinum toxin substrate 1 | Homo sapiens | Inhibition | = | 27 | % | 24440300 |
NPT2656 | Individual Protein | Ras-related C3 botulinum toxin substrate 1 | Homo sapiens | Inhibition | = | 22 | % | 24440300 |
NPT2656 | Individual Protein | Ras-related C3 botulinum toxin substrate 1 | Homo sapiens | Inhibition | = | 14 | % | 24440300 |
NPT1654 | Individual Protein | Urokinase-type plasminogen activator | Homo sapiens | Activity | = | 61 | % | 24440300 |
NPT1654 | Individual Protein | Urokinase-type plasminogen activator | Homo sapiens | Activity | = | 25 | % | 24440300 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 38 | % | 24440300 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 29 | % | 24440300 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 20 | % | 24440300 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 76 | % | 24440300 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 59 | % | 24440300 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 25 | % | 24440300 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Activity | = | 40 | % | 24440300 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Activity | = | 6 | % | 24440300 |
NPT1604 | Individual Protein | Cytochrome P450 1B1 | Homo sapiens | IC50 | = | 1400 | nM | 10.1039/C3MD00317E |
NPT1604 | Individual Protein | Cytochrome P450 1B1 | Homo sapiens | Ki | = | 900 | nM | 10.1039/C0MD00242A |
NPT1603 | Individual Protein | Cytochrome P450 1A1 | Homo sapiens | Ki | = | 570 | nM | 10.1039/C0MD00242A |
NPT1173 | Organism | Candida albicans SC5314 | Candida albicans SC5314 | MIC95 | = | 28 | ug/ml | 25014026 |
NPT2580 | Organism | Candida dubliniensis | Candida dubliniensis | MIC95 | = | 14 | ug/ml | 25014026 |
NPT3676 | Organism | Candida famata | Candida famata | MIC95 | = | 7 | ug/ml | 25014026 |
NPT554 | Organism | Candida glabrata | Candida glabrata | MIC95 | = | 28 | ug/ml | 25014026 |
NPT2578 | Organism | Pichia guilliermondii | Meyerozyma guilliermondii | MIC95 | = | 7 | ug/ml | 25014026 |
NPT3678 | Organism | Candida inconspicua | Candida inconspicua | MIC95 | = | 28 | ug/ml | 25014026 |
NPT3153 | Organism | Kluyveromyces marxianus | Kluyveromyces marxianus | MIC95 | = | 14 | ug/ml | 25014026 |
NPT187 | Organism | Issatchenkia orientalis | Pichia kudriavzevii | MIC95 | = | 28 | ug/ml | 25014026 |
NPT820 | Organism | Clavispora lusitaniae | Clavispora lusitaniae | MIC95 | = | 28 | ug/ml | 25014026 |
NPT3677 | Organism | Pichia norvegensis | Pichia norvegensis | MIC95 | = | 28 | ug/ml | 25014026 |
NPT188 | Organism | Candida parapsilosis | Candida parapsilosis | MIC95 | = | 14 | ug/ml | 25014026 |
NPT186 | Organism | Candida tropicalis | Candida tropicalis | MIC95 | = | 28 | ug/ml | 25014026 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | > | 60000 | nM | 26204233 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | > | 60000 | nM | 26204233 |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | IC50 | > | 10000 | nM | 26750258 |
NPT1534 | Individual Protein | Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus | EC50 | = | 3600 | nM | 26750258 |
NPT1534 | Individual Protein | Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus | IC50 | = | 7500 | nM | 26750258 |
NPT2 | Others | Unspecified | Ratio | = | 4.32 | 26947607 | ||
NPT1651 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Mus musculus | FC | = | 2 | 27312421 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC180508 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC228287 |
0.9811 | High Similarity | NPC280606 |
0.9725 | High Similarity | NPC474933 |
0.9717 | High Similarity | NPC296920 |
0.9717 | High Similarity | NPC90520 |
0.9633 | High Similarity | NPC141090 |
0.9623 | High Similarity | NPC94045 |
0.9541 | High Similarity | NPC53906 |
0.9528 | High Similarity | NPC82016 |
0.9455 | High Similarity | NPC203113 |
0.945 | High Similarity | NPC22610 |
0.945 | High Similarity | NPC276737 |
0.9381 | High Similarity | NPC102639 |
0.9381 | High Similarity | NPC166759 |
0.9369 | High Similarity | NPC219070 |
0.9369 | High Similarity | NPC15860 |
0.9369 | High Similarity | NPC127894 |
0.9369 | High Similarity | NPC195466 |
0.9369 | High Similarity | NPC33270 |
0.9369 | High Similarity | NPC69261 |
0.9369 | High Similarity | NPC470759 |
0.9364 | High Similarity | NPC464 |
0.9364 | High Similarity | NPC185541 |
0.934 | High Similarity | NPC35543 |
0.9298 | High Similarity | NPC476633 |
0.9292 | High Similarity | NPC474565 |
0.9279 | High Similarity | NPC85292 |
0.9279 | High Similarity | NPC150624 |
0.9279 | High Similarity | NPC114064 |
0.9279 | High Similarity | NPC54507 |
0.9279 | High Similarity | NPC229147 |
0.9252 | High Similarity | NPC245115 |
0.9245 | High Similarity | NPC164576 |
0.9217 | High Similarity | NPC262253 |
0.9217 | High Similarity | NPC473411 |
0.9217 | High Similarity | NPC71579 |
0.9204 | High Similarity | NPC184302 |
0.9204 | High Similarity | NPC226629 |
0.9189 | High Similarity | NPC808 |
0.9189 | High Similarity | NPC167934 |
0.9174 | High Similarity | NPC255068 |
0.9138 | High Similarity | NPC282496 |
0.9138 | High Similarity | NPC233526 |
0.9138 | High Similarity | NPC136319 |
0.9115 | High Similarity | NPC131118 |
0.9115 | High Similarity | NPC190514 |
0.9083 | High Similarity | NPC168657 |
0.9083 | High Similarity | NPC2682 |
0.906 | High Similarity | NPC270030 |
0.9057 | High Similarity | NPC474603 |
0.9057 | High Similarity | NPC12987 |
0.9027 | High Similarity | NPC50521 |
0.9027 | High Similarity | NPC221549 |
0.9027 | High Similarity | NPC244816 |
0.8983 | High Similarity | NPC233410 |
0.8983 | High Similarity | NPC116907 |
0.8983 | High Similarity | NPC234400 |
0.8983 | High Similarity | NPC57490 |
0.8983 | High Similarity | NPC298757 |
0.8983 | High Similarity | NPC203133 |
0.8983 | High Similarity | NPC251855 |
0.8983 | High Similarity | NPC472093 |
0.8983 | High Similarity | NPC117214 |
0.8983 | High Similarity | NPC221077 |
0.8983 | High Similarity | NPC193544 |
0.8983 | High Similarity | NPC265483 |
0.8983 | High Similarity | NPC105031 |
0.8983 | High Similarity | NPC475169 |
0.8983 | High Similarity | NPC82483 |
0.8983 | High Similarity | NPC17943 |
0.8983 | High Similarity | NPC208950 |
0.8983 | High Similarity | NPC113495 |
0.8983 | High Similarity | NPC105925 |
0.8983 | High Similarity | NPC60885 |
0.8983 | High Similarity | NPC299584 |
0.8966 | High Similarity | NPC75713 |
0.8957 | High Similarity | NPC247364 |
0.8957 | High Similarity | NPC10932 |
0.8957 | High Similarity | NPC232084 |
0.8957 | High Similarity | NPC61516 |
0.8938 | High Similarity | NPC123948 |
0.8908 | High Similarity | NPC28730 |
0.8908 | High Similarity | NPC78974 |
0.8908 | High Similarity | NPC170485 |
0.8908 | High Similarity | NPC214406 |
0.8908 | High Similarity | NPC223136 |
0.8908 | High Similarity | NPC18924 |
0.8908 | High Similarity | NPC103823 |
0.8908 | High Similarity | NPC44748 |
0.8899 | High Similarity | NPC75440 |
0.8889 | High Similarity | NPC18128 |
0.8889 | High Similarity | NPC41562 |
0.8889 | High Similarity | NPC77789 |
0.886 | High Similarity | NPC259638 |
0.8833 | High Similarity | NPC236791 |
0.8833 | High Similarity | NPC127587 |
0.8833 | High Similarity | NPC210355 |
0.8833 | High Similarity | NPC159968 |
0.8833 | High Similarity | NPC82679 |
0.8833 | High Similarity | NPC324112 |
0.8833 | High Similarity | NPC246620 |
0.8833 | High Similarity | NPC74817 |
0.8833 | High Similarity | NPC124452 |
0.8833 | High Similarity | NPC473221 |
0.8833 | High Similarity | NPC282000 |
0.8833 | High Similarity | NPC293054 |
0.8833 | High Similarity | NPC169474 |
0.8814 | High Similarity | NPC197757 |
0.8814 | High Similarity | NPC228922 |
0.8814 | High Similarity | NPC95168 |
0.8814 | High Similarity | NPC84086 |
0.8814 | High Similarity | NPC474160 |
0.8774 | High Similarity | NPC275053 |
0.8774 | High Similarity | NPC248573 |
0.8774 | High Similarity | NPC161571 |
0.8772 | High Similarity | NPC193067 |
0.876 | High Similarity | NPC470213 |
0.876 | High Similarity | NPC98631 |
0.876 | High Similarity | NPC206615 |
0.876 | High Similarity | NPC186843 |
0.875 | High Similarity | NPC223953 |
0.875 | High Similarity | NPC76451 |
0.875 | High Similarity | NPC82299 |
0.8739 | High Similarity | NPC138248 |
0.8739 | High Similarity | NPC5796 |
0.8739 | High Similarity | NPC206487 |
0.8739 | High Similarity | NPC122792 |
0.8739 | High Similarity | NPC303521 |
0.8739 | High Similarity | NPC228972 |
0.8739 | High Similarity | NPC228503 |
0.8729 | High Similarity | NPC100099 |
0.8729 | High Similarity | NPC74137 |
0.8729 | High Similarity | NPC36016 |
0.8727 | High Similarity | NPC201959 |
0.8716 | High Similarity | NPC113457 |
0.8707 | High Similarity | NPC137294 |
0.8707 | High Similarity | NPC295259 |
0.8707 | High Similarity | NPC85895 |
0.8707 | High Similarity | NPC475961 |
0.8707 | High Similarity | NPC20674 |
0.8707 | High Similarity | NPC254625 |
0.8689 | High Similarity | NPC58164 |
0.8689 | High Similarity | NPC10225 |
0.8689 | High Similarity | NPC228769 |
0.8689 | High Similarity | NPC471519 |
0.8689 | High Similarity | NPC170844 |
0.8689 | High Similarity | NPC476968 |
0.8689 | High Similarity | NPC470633 |
0.8689 | High Similarity | NPC471518 |
0.8689 | High Similarity | NPC190144 |
0.8678 | High Similarity | NPC46978 |
0.8667 | High Similarity | NPC278955 |
0.8667 | High Similarity | NPC105718 |
0.8661 | High Similarity | NPC203924 |
0.8655 | High Similarity | NPC76465 |
0.8655 | High Similarity | NPC38761 |
0.8644 | High Similarity | NPC212965 |
0.8644 | High Similarity | NPC145780 |
0.8644 | High Similarity | NPC54972 |
0.8632 | High Similarity | NPC229401 |
0.8621 | High Similarity | NPC74821 |
0.8618 | High Similarity | NPC51840 |
0.8618 | High Similarity | NPC224157 |
0.8618 | High Similarity | NPC472338 |
0.8618 | High Similarity | NPC63574 |
0.8618 | High Similarity | NPC234488 |
0.8618 | High Similarity | NPC254000 |
0.8618 | High Similarity | NPC299221 |
0.8618 | High Similarity | NPC126836 |
0.8618 | High Similarity | NPC192687 |
0.8618 | High Similarity | NPC311680 |
0.8607 | High Similarity | NPC28765 |
0.8607 | High Similarity | NPC154866 |
0.8607 | High Similarity | NPC215300 |
0.8595 | High Similarity | NPC283049 |
0.8595 | High Similarity | NPC50315 |
0.8595 | High Similarity | NPC230479 |
0.8595 | High Similarity | NPC26879 |
0.8585 | High Similarity | NPC291789 |
0.8583 | High Similarity | NPC197351 |
0.8583 | High Similarity | NPC106914 |
0.8583 | High Similarity | NPC86502 |
0.8583 | High Similarity | NPC140521 |
0.8583 | High Similarity | NPC134195 |
0.8583 | High Similarity | NPC246648 |
0.8571 | High Similarity | NPC120638 |
0.8559 | High Similarity | NPC199023 |
0.8559 | High Similarity | NPC218753 |
0.8559 | High Similarity | NPC472596 |
0.8548 | High Similarity | NPC470096 |
0.8548 | High Similarity | NPC45715 |
0.8548 | High Similarity | NPC472597 |
0.8548 | High Similarity | NPC471517 |
0.8548 | High Similarity | NPC282508 |
0.8548 | High Similarity | NPC474017 |
0.8548 | High Similarity | NPC473309 |
0.8548 | High Similarity | NPC12275 |
0.8548 | High Similarity | NPC474356 |
0.8548 | High Similarity | NPC470095 |
0.8548 | High Similarity | NPC15543 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC180508 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8774 | High Similarity | NPD1242 | Phase 1 |
0.8689 | High Similarity | NPD3027 | Phase 3 |
0.8621 | High Similarity | NPD1548 | Phase 1 |
0.85 | High Similarity | NPD2982 | Phase 2 |
0.85 | High Similarity | NPD2983 | Phase 2 |
0.8487 | Intermediate Similarity | NPD1610 | Phase 2 |
0.8455 | Intermediate Similarity | NPD4908 | Phase 1 |
0.8417 | Intermediate Similarity | NPD2981 | Phase 2 |
0.832 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.824 | Intermediate Similarity | NPD4625 | Phase 3 |
0.8226 | Intermediate Similarity | NPD3018 | Phase 2 |
0.8197 | Intermediate Similarity | NPD4749 | Approved |
0.816 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.808 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8047 | Intermediate Similarity | NPD1613 | Approved |
0.8047 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.8033 | Intermediate Similarity | NPD422 | Phase 1 |
0.8018 | Intermediate Similarity | NPD940 | Approved |
0.8018 | Intermediate Similarity | NPD846 | Approved |
0.8017 | Intermediate Similarity | NPD228 | Approved |
0.8 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.7963 | Intermediate Similarity | NPD2933 | Approved |
0.7963 | Intermediate Similarity | NPD2934 | Approved |
0.7937 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7903 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7903 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7895 | Intermediate Similarity | NPD968 | Approved |
0.7891 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7891 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.789 | Intermediate Similarity | NPD2859 | Approved |
0.789 | Intermediate Similarity | NPD2860 | Approved |
0.7881 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7845 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7838 | Intermediate Similarity | NPD3020 | Approved |
0.7769 | Intermediate Similarity | NPD1240 | Approved |
0.775 | Intermediate Similarity | NPD6671 | Approved |
0.7717 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7692 | Intermediate Similarity | NPD5451 | Approved |
0.7652 | Intermediate Similarity | NPD1607 | Approved |
0.7623 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7609 | Intermediate Similarity | NPD4357 | Discontinued |
0.7607 | Intermediate Similarity | NPD2684 | Approved |
0.7556 | Intermediate Similarity | NPD3540 | Phase 1 |
0.7542 | Intermediate Similarity | NPD3022 | Approved |
0.7542 | Intermediate Similarity | NPD3021 | Approved |
0.7537 | Intermediate Similarity | NPD1510 | Phase 2 |
0.75 | Intermediate Similarity | NPD2238 | Phase 2 |
0.75 | Intermediate Similarity | NPD1357 | Approved |
0.7481 | Intermediate Similarity | NPD3539 | Phase 1 |
0.7481 | Intermediate Similarity | NPD6100 | Approved |
0.7481 | Intermediate Similarity | NPD6099 | Approved |
0.748 | Intermediate Similarity | NPD6582 | Phase 2 |
0.748 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7453 | Intermediate Similarity | NPD111 | Approved |
0.744 | Intermediate Similarity | NPD2667 | Approved |
0.744 | Intermediate Similarity | NPD2668 | Approved |
0.744 | Intermediate Similarity | NPD4626 | Approved |
0.7436 | Intermediate Similarity | NPD3134 | Approved |
0.7429 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7429 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7402 | Intermediate Similarity | NPD2230 | Approved |
0.7402 | Intermediate Similarity | NPD2232 | Approved |
0.7402 | Intermediate Similarity | NPD2233 | Approved |
0.7402 | Intermediate Similarity | NPD1608 | Approved |
0.7381 | Intermediate Similarity | NPD3847 | Discontinued |
0.7373 | Intermediate Similarity | NPD290 | Approved |
0.7372 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7368 | Intermediate Similarity | NPD1558 | Phase 1 |
0.736 | Intermediate Similarity | NPD1651 | Approved |
0.7357 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7357 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7355 | Intermediate Similarity | NPD821 | Approved |
0.7355 | Intermediate Similarity | NPD7843 | Approved |
0.7355 | Intermediate Similarity | NPD5535 | Approved |
0.7353 | Intermediate Similarity | NPD2935 | Discontinued |
0.7344 | Intermediate Similarity | NPD1669 | Approved |
0.7339 | Intermediate Similarity | NPD9295 | Approved |
0.7323 | Intermediate Similarity | NPD1091 | Approved |
0.7321 | Intermediate Similarity | NPD1432 | Clinical (unspecified phase) |
0.7317 | Intermediate Similarity | NPD7157 | Approved |
0.7317 | Intermediate Similarity | NPD709 | Approved |
0.7308 | Intermediate Similarity | NPD4624 | Approved |
0.7302 | Intermediate Similarity | NPD1778 | Approved |
0.7299 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7299 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7292 | Intermediate Similarity | NPD4675 | Approved |
0.7292 | Intermediate Similarity | NPD4678 | Approved |
0.7287 | Intermediate Similarity | NPD1283 | Approved |
0.728 | Intermediate Similarity | NPD1182 | Approved |
0.7266 | Intermediate Similarity | NPD3892 | Phase 2 |
0.7266 | Intermediate Similarity | NPD3750 | Approved |
0.7266 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7266 | Intermediate Similarity | NPD2231 | Phase 2 |
0.726 | Intermediate Similarity | NPD2801 | Approved |
0.726 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7259 | Intermediate Similarity | NPD4097 | Suspended |
0.7257 | Intermediate Similarity | NPD844 | Approved |
0.7246 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7234 | Intermediate Similarity | NPD1511 | Approved |
0.7227 | Intermediate Similarity | NPD1358 | Approved |
0.7226 | Intermediate Similarity | NPD2796 | Approved |
0.7226 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7222 | Intermediate Similarity | NPD5585 | Approved |
0.7214 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7214 | Intermediate Similarity | NPD2219 | Phase 1 |
0.7194 | Intermediate Similarity | NPD3060 | Approved |
0.7194 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.7192 | Intermediate Similarity | NPD1934 | Approved |
0.7188 | Intermediate Similarity | NPD3705 | Approved |
0.7185 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7185 | Intermediate Similarity | NPD5124 | Phase 1 |
0.717 | Intermediate Similarity | NPD9089 | Approved |
0.7165 | Intermediate Similarity | NPD5846 | Approved |
0.7165 | Intermediate Similarity | NPD2423 | Clinical (unspecified phase) |
0.7165 | Intermediate Similarity | NPD17 | Approved |
0.7165 | Intermediate Similarity | NPD6516 | Phase 2 |
0.7163 | Intermediate Similarity | NPD7124 | Phase 2 |
0.7162 | Intermediate Similarity | NPD3882 | Suspended |
0.7154 | Intermediate Similarity | NPD3225 | Approved |
0.7154 | Intermediate Similarity | NPD6696 | Suspended |
0.7143 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD7095 | Approved |
0.7143 | Intermediate Similarity | NPD1894 | Discontinued |
0.7133 | Intermediate Similarity | NPD1512 | Approved |
0.7132 | Intermediate Similarity | NPD2568 | Approved |
0.7132 | Intermediate Similarity | NPD3052 | Approved |
0.7132 | Intermediate Similarity | NPD3054 | Approved |
0.712 | Intermediate Similarity | NPD3596 | Phase 2 |
0.7111 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7111 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7109 | Intermediate Similarity | NPD3496 | Discontinued |
0.7103 | Intermediate Similarity | NPD4005 | Discontinued |
0.7099 | Intermediate Similarity | NPD2797 | Approved |
0.709 | Intermediate Similarity | NPD3145 | Approved |
0.709 | Intermediate Similarity | NPD3144 | Approved |
0.7087 | Intermediate Similarity | NPD5691 | Approved |
0.708 | Intermediate Similarity | NPD6111 | Discontinued |
0.708 | Intermediate Similarity | NPD4538 | Approved |
0.708 | Intermediate Similarity | NPD4536 | Approved |
0.708 | Intermediate Similarity | NPD4537 | Clinical (unspecified phase) |
0.7077 | Intermediate Similarity | NPD5327 | Phase 3 |
0.7075 | Intermediate Similarity | NPD9093 | Approved |
0.7075 | Intermediate Similarity | NPD37 | Approved |
0.7063 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD5735 | Approved |
0.7059 | Intermediate Similarity | NPD230 | Phase 1 |
0.7055 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7054 | Intermediate Similarity | NPD1281 | Approved |
0.7054 | Intermediate Similarity | NPD1535 | Discovery |
0.7043 | Intermediate Similarity | NPD288 | Approved |
0.7037 | Intermediate Similarity | NPD2674 | Phase 3 |
0.7034 | Intermediate Similarity | NPD1653 | Approved |
0.7027 | Intermediate Similarity | NPD7819 | Suspended |
0.7023 | Intermediate Similarity | NPD8651 | Approved |
0.7021 | Intermediate Similarity | NPD7466 | Approved |
0.7021 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7018 | Intermediate Similarity | NPD9296 | Approved |
0.7009 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7009 | Intermediate Similarity | NPD3028 | Approved |
0.7008 | Intermediate Similarity | NPD6580 | Approved |
0.7008 | Intermediate Similarity | NPD6581 | Approved |
0.7008 | Intermediate Similarity | NPD3091 | Approved |
0.7008 | Intermediate Similarity | NPD9545 | Approved |
0.7007 | Intermediate Similarity | NPD1772 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD1840 | Phase 2 |
0.7 | Intermediate Similarity | NPD1481 | Phase 2 |
0.6993 | Remote Similarity | NPD6799 | Approved |
0.6993 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6992 | Remote Similarity | NPD4993 | Discontinued |
0.6992 | Remote Similarity | NPD9494 | Approved |
0.6985 | Remote Similarity | NPD4140 | Approved |
0.698 | Remote Similarity | NPD8443 | Clinical (unspecified phase) |
0.6966 | Remote Similarity | NPD6980 | Clinical (unspecified phase) |
0.6954 | Remote Similarity | NPD6234 | Discontinued |
0.6953 | Remote Similarity | NPD6830 | Clinical (unspecified phase) |
0.695 | Remote Similarity | NPD4236 | Phase 3 |
0.695 | Remote Similarity | NPD4237 | Approved |
0.695 | Remote Similarity | NPD1652 | Phase 2 |
0.6947 | Remote Similarity | NPD3676 | Clinical (unspecified phase) |
0.6947 | Remote Similarity | NPD4359 | Approved |
0.6944 | Remote Similarity | NPD4123 | Phase 3 |
0.694 | Remote Similarity | NPD600 | Approved |
0.694 | Remote Similarity | NPD1008 | Clinical (unspecified phase) |
0.694 | Remote Similarity | NPD596 | Approved |
0.694 | Remote Similarity | NPD5752 | Clinical (unspecified phase) |
0.6935 | Remote Similarity | NPD7635 | Approved |
0.6934 | Remote Similarity | NPD4340 | Discontinued |
0.6933 | Remote Similarity | NPD4965 | Approved |
0.6933 | Remote Similarity | NPD4868 | Clinical (unspecified phase) |
0.6933 | Remote Similarity | NPD4967 | Phase 2 |
0.6933 | Remote Similarity | NPD4966 | Approved |
0.6933 | Remote Similarity | NPD7768 | Phase 2 |
0.6929 | Remote Similarity | NPD7266 | Discontinued |
0.6928 | Remote Similarity | NPD6232 | Discontinued |
0.6923 | Remote Similarity | NPD3092 | Approved |
0.6917 | Remote Similarity | NPD3690 | Phase 2 |
0.6917 | Remote Similarity | NPD3691 | Phase 2 |
0.6912 | Remote Similarity | NPD6233 | Phase 2 |
0.6906 | Remote Similarity | NPD5960 | Phase 3 |
PubChem CID   | 5281727 |
ChEMBL   | CHEMBL83527 |
ZINC   |
Molecular Weight:   | 256.11 |
ALogP:   | -0.0961 |
MLogP:   | 2.89 |
XLogP:   | 4.474 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 38.69 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 1 |
# Rings:   | 2 |
# Heavy Atoms:   | 19 |